Cardio Care Today Content Partners
Advertisement
The Latest From Our Partners
OCTIVUS shows PCI outcomes improve with EAPCI-defined stent optimization, regardless of imaging modality.
MITT and safety data show acoramidis significantly lowers AFib-related events in transthyretin cardiac amyloidosis.
LuX-Valve offers a safe, effective option for severe TR patients at high surgical risk.
ESC 2025: Acoramidis may reduce AF/flutter burden in ATTR-CM, per new ATTRibute-CM trial analysis discussed by CardioNerds.
CTA-first screening before TAVR avoids invasive angiography in 53% of patients—without compromising outcomes.
Delays in TAVI for acute decompensated aortic stenosis worsen outcomes.
Cardio Care Todaty delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get insights and commentary from our partners straight to your inbox.